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 Abstract 
  Background/Aims:  The present study was conducted to investigate the renal tubular handling 
of inorganic cadmium (Cd  2+  ) by exposing primary human tubular cell cultures to physiologi-
cally relevant doses of cadmium chloride (CdCl  2 ). Furthermore, the cellular accumulation of Cd  2+  
was compared to that of metallothionein-1-bound Cd (Cd7MT-1). Finally, this study aimed to in-
vestigate the effect of the accumulation of Cd (both Cd  2+   and Cd7MT-1) in renal cells on the ex-
pression of genes relevant to nephrotoxic processes.  Methods:  Cd concentration was measured 
using atomic absorption spectrometry. mRNA expression was evaluated by quantitative real-
time RT-PCR.  Results:  Cd 2+  accumulated into human tubular cells in a concentration- and time-
dependent way. Furthermore, cellular accumulation of Cd  2+   was different from the cellular ac-
cumulation of Cd7MT-1, indicative for different uptake routes. Finally, mRNA expression of the 
genes encoding the anti-oxidative proteins metallothionein-1 (MT-1) and heme-oxygenase-1 
(HO-1) as well as the pro-apoptotic Bcl-2-associated X protein (Bax) were upregulated by CdCl  2  
and not by Cd7MT1.  Conclusion:  In the presence of physiologically relevant Cd concentrations, 
tubular accumulation of the element in its inorganic form is different from that of Cd7MT-1. Fur-
thermore, the tubular accumulation of inorganic Cd induces mRNA expression of genes of 
which the protein products may play a role in Cd-associated renal toxicity. 
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 Introduction 
 Cadmium (Cd) is one of the most toxic metals present in our environment. Major sourc-
es of Cd exposure include contaminated food and water, industrial fumes and dusts   [1]  , but 
cigarette smoke is by far the largest source of Cd exposure in the general human population 
  [2]  . Each cigarette may contain 1–2     g of Cd, and 40–60% of the Cd in inhaled smoke gen-
erally passes through the pulmonary epithelium into systemic circulation   [3, 4]  .
  In humans and other mammals, increased exposure to Cd adversely affects a number of 
organs and tissues, including the kidneys, liver, lung, pancreas, testis, placenta, and bone. 
Out of these, the effect on the kidneys is the earliest and most important and consists pri-
marily of tubular damage and concomitant low-molecular-weight proteinuria   [5–9]  . In fact, 
based on epidemiological and toxicological studies in humans and investigations in animals, 
the International Agency for Research on Cancer (IARC) has classified Cd as a Category I 
carcinogen (IARC, 1993).
  Environmental/occupational exposure to the non-essential metal Cd, together with var-
ious other elements such as lead, mercury and arsenic, is a known hazard to human health. 
The first reliable information on Cd levels in humans originates from studies in the seventies 
together with the availability of instrumentation and techniques allowing accurate measure-
ment of the low concentrations in which the element circulates in the blood compartment or 
accumulates in tissues. Already in 1979, Lauwerys et al.  [10]  reported that blood Cd levels up 
to 0.1     M   (11.2     g/l) in workers chronically exposed to Cd correlated with an increased risk 
for renal dysfunction, predominantly of tubular origin. Normal whole-blood Cd levels in the 
general population have been reported to be  ! 0.02     M   (2.25    g/l). In 1990, Minoia et al.   [11]   
reported normal-blood Cd levels ranging from 0.005 to 0.05     M   (0.56 up to 5.6     g/l) in the 
healthy European population. Significantly elevated values were found in occupationally ex-
posed workers and in people living in the proximity of Cd-processing industries, particu-
larly in smokers   [12, 13]  . Most of the in vitro and experimental studies investigating the 
toxic effects of Cd were performed in the presence of Cd concentrations that were orders of 
magnitude higher than those encountered in vivo.
    Cd taken up via inhalation and/or ingestion undergoes hepatic conversion into the Cd-
metallothionein (Cd7MT-1) complex. Cd7MT-1 (MW: 3,500–14,000 Da) is filtered by the 
glomerulus and taken up by the proximal tubular cells via receptor-mediated endocytosis 
(RME). However, arguments exist that also inorganic (free ionic) Cd (Cd  2+  ) plays a substan-
tial role in renal toxicity. In this context, the finding that Cd bound to small peptides may be 
released at the brush border after which it is taken up in its free ionic form by renal cells is 
of particular interest  [14] . Furthermore, besides affecting the paracellular transport of essen-
tial divalent cations   [14, 15]  , tubular damage caused by Cd diminishes the active transcellu-
lar transport of Na  +  and K  +   [16] . Cd exposure has also been associated with increased urinary 
calcium (Ca  2+  ) excretion and renal stone formation, which can be the consequence of a Cd-
induced bone pathology either manifested by an increased calcium efflux out of the bone, a 
decreased incorporation of the element into the bone   [17]  , and/or blockage of the epithelial 
calcium channels  [18] . In view of these findings, it seems reasonably that inorganic Cd, along 
with the methylated form, is taken up by renal tubular cells.
    Little is known concerning the renal (tubular) handling of Cd in its inorganic form 
(Cd  2+  ), and although it probably accounts for only a minor fraction of the renal Cd uptake 
in vivo, studying tubular handling of inorganic Cd is of particular interest in view of its po-
tential toxicity.
    The present study was conducted to investigate the renal tubular handling of Cd  2+   by 
exposing primary human tubular cell cultures to physiologically relevant doses of Cd  2+   (ad-
ministered as CdCl  2  ). Furthermore, the cellular accumulation of Cd  2+   was compared to that 26
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of Cd7MT-1 and, finally, this study aimed to investigate the effect of the accumulation of Cd 
(both Cd  2+   and MT complexes) in renal cells on the expression of several genes relevant to 
nephrotoxic processes.
  Materials  and  Methods 
  Isolation, Purification and Cultivation of Primary Human Kidney Tubular Cells 
 Human kidney tubular epithelial cells were isolated as described previously  [19] . Brief-
ly, normal human kidney tissue that became available through nephrectomy performed 
upon oncological indication was collected and processed in a sterile manner. The cortex 
and outer stripe of outer medulla were dissected, cut into pieces of about 1 mm  3   and di-
gested in collagenase D solution (Roche, Ottweiler, Germany). The suspension was shaken 
vigorously for 2 h at 37    °   C and sieved through a 120-  m sieve. The resulting cell suspension 
was loaded on top of a discontinuous Percoll (Amersham Pharmacia Biotech, Uppsala, 
Sweden) gradient with densities of 1.04 and 1.07 g/ml. After centrifugation tubular cells 
were carefully aspirated from the intersection, washed, and brought into culture. Cells were 
seeded in 24-well plates (25,000 cells/well) in     -MEM medium (Life Technologies, Rock-
ville, Md., USA) modified according to Gibson d’Ambrosio, supplemented with 10% fetal 
calf serum and grown until confluence (  8  6 days). Twenty-four hours before studying the 
Cd  2+   uptake, the serum-containing medium was replaced by serum-free    -MEM  Gibson 
d’Ambrosio.
    Measurement of the Cellular Cd Concentration 
  Cell cultures were exposed to CdCl  2   dissolved in     -MEM medium (37    °    C) at different 
concentrations (0–1,000 n  M  ) for 5 h. Furthermore, cell cultures were exposed to CdCl  2   or 
Cd7MT-1 (Bestenbalt, Tallinn, Estonia) for different time periods (3–72 h) at 500 n  M   (for 
both compounds, concentrations correspond to the metal concentration).
    After incubation, cells were extensively rinsed with PBS (3 times) and lysed during 20 
min with 0.1% Triton X-100 in PBS. The lysate was divided in aliquots and stored at –20    °   C 
(some aliquots were also stored at –80    °    C for gene expression studies).
    At the time of analysis, 0.5 ml of the lysates were digested in ultrapure HNO  3   (Merck 
Suprapur 4371) at 70    °    C for 24 h. Digests were subsequently mixed with a matrix modifier 
consisting of diammonium hydrogen phosphate (0.5 g/100 ml), magnesium nitrate [0.24 
g/100 ml and Triton X-100 (0.1% m/v)]. The Cd concentration was measured against a ma-
trix-modified aqueous calibration curve with standards prepared from a stock solution of 
1,000     g/ml Cd (Merck Titrisol 9960) and using a Zeeman 3030 atomic absorption spec-
trometer equipped with an HGA graphite furnace, an AS-60 autosampler, and an Anadex 
DP-9500B silent scribe printer, all from Perkin-Elmer (Norwalk, Conn., USA).
    In order to evaluate the cellular response to the anti-oxidant compound ebselen, the lat-
ter compound was added to serum-free     -MEM at a 10    M   concentration for 1 h. Cells were 
then washed 3 times with serum-free medium and were exposed to different CdCl  2   concen-
trations (in the absence of ebselen) for 5 h.
    To check the effect of zinc (Zn) on cellular Cd  2+   uptake, 5     M   ZnCl 2   was administered 
to confluent monolayers 1 h before addition of 500 n  M  CdCl 2 . Cd 2+  uptake was then assessed 
(still in the presence of Zn) after 1, 5, and 20 h.
    To evaluate the effect of pH on Cd  2+   uptake, parallel experiments were performed in 
glucose-containing HEPES or 2-(  N  -morpholino)ethanesulfonic acid (MES) solutions buf  f-
ered at pH 7.4 and 5.5, respectively, for 1, 5, 15, and 20 h.27
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    In order to allow the cellular Cd concentration to be expressed per milligram protein, 
the protein concentration of the cell lysates was determined using a BCA kit (Perbio, Bel-
gium) according to the manufacturer’s instructions.
    RNA Isolation and Quantitative Real-Time RT-PCR Analysis 
  Total RNA was extracted from cell lysates using the RNeasy Micro Kit (Qiagen, Hilden, 
Germany). cDNA was synthesized using the High-Capacity cDNA Archive Kit (ABI, Nieu-
werkerk a/d IJssel, The Netherlands), and mRNA expression was evaluated by quantitative 
real-time PCR on the ABI Prism 7000 Sequence Detection System (ABI) using the fluorescent 
Taqman methodology. Ready-to-use primer and probe sets were pre-designed by Applied 
  Biosystems for the following genes: divalent metal transporter 1 (DMT-1; Hs00167206_m1), 
metallothionein-1 (MT-1; Hs00831826_s1), heme-oxygenase-1 (HO-1; Hs00157965_m1), 
  B-cell CLL/lymphoma 2 (Bcl-2; Hs00153350_m1), and Bcl-2-associated X protein (Bax; 
Hs99999001_m1). Instructions of the supplier were followed for PCR conditions, which were 
uniform for all assays under study. The relative mRNA expression of the different genes was an-
alyzed in triplicate, normalized against glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 
Hs99999905_m1) as a control housekeeping gene and expressed in relation to a calibrator 
sample using the comparative Ct method. Control (untreated) cells served as calibrator sample 
which was given a gene of interest/GAPDH mRNA expression ratio value of 1.
  S t a t i s t i c s  
  Data are expressed as the means   8   SEM. To analyze saturation curves, non-linear re-
gression was fitted to a Michaelis-Menten equation using OriginLab version 8. Differences 
in Cd uptake and mRNA levels were tested for significance using the non-parametric Krus-
kal-Wallis test for multiple group comparison, followed by the Mann-Whitney U test for 
comparisons between 2 groups using SPSS Statistics 17.0 software.
  R e s u l t s  
  Intracellular Cd Accumulation in Primary Human Tubular Kidney Cells 
  We first examined whether physiologically relevant concentrations of Cd  2+   (0, 20, 100, 
200, and 500 n  M   of CdCl  2  ) are taken up by renal tubular cells during an incubation time of 
5 h. The dose-response curve depicted in   figure 1  a shows that the accumulation of Cd in the 
tubular cells is saturable, with a maximal cellular uptake of 641   8   76 pmol Cd/mg protein.
      Figure 1  b shows the kinetics of intracellular Cd accumulation by confluent cells incu-
bated with serum-free culture medium containing 500 n  M   CdCl 2   in function of time (filled 
circles curve). Cellular Cd rapidly increased with time and more or less reached a plateau 
after 24 h with a maximal value of 772   8   354 pmol/mg protein after 72 h of exposure. We 
performed concomitant measurements of the Cd concentration in the extracellular medium. 
During 72 h of exposure and in line with the cellular uptake, the Cd concentration in the 
extracellular medium gradually decreased to 21.5   8   2 pmol/mg protein. The time-depen-
dent intracellular accumulation of Cd  2+   was compared to that of Cd7MT-1 (500 n  M ;  open 
circles curve). The final amount of Cd present in the tubular cells after 72 h of incubation, 
as well as the accumulation kinetics with either CdCl  2  or Cd7MT-1 were significantly differ-
ent. Whilst the Cd concentration in cells treated with inorganic CdCl  2   reached a plateau af-
ter 24 h of incubation (p   1   0.05 between values noted after 24, 48, or 72 h of exposure), ad-
dition of Cd to the culture medium in the Cd7MT-1 complex resulted in a linear and steady 
increase in the Cd levels from 5 h (p  !  0.05 vs. 24, 48, and 72 h) until 72 h of exposure, reach-
ing a maximal cellular concentration of 407   8   28 pmol/mg protein.28
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    Effect of pH and Zn on Intracellular Cd Accumulation 
  To evaluate the effect of pH on the intracellular Cd accumulation during exposure to 
CdCl  2  , cells were incubated for different periods with 20 n  M   CdCl 2   in glucose-containing 
HEPES- (pH 7.4) and MES- (pH 5.5) buffered solutions. The intracellular Cd accumulation 
was significantly higher (p   !   0.05) in cells that were incubated in the acidic buffer (  fig. 2  a).
    To determine whether Zn would affect Cd accumulation, cultures were incubated with 
5    M  ZnCl 2  (1 h before and during the whole CdCl  2  incubation period). The intracellular Cd 
concentration decreased from 632   8   199 to 149   8   100 pmol/mg protein in the presence of 
Zn  2+   ( fig. 2 b).
    Possible Involvement of DMT Proteins in Cellular Cd Uptake 
  The observation that the accumulation of Cd  2+   in the tubular cells is pH dependent and 
dramatically affected by the presence of other divalent cations (such as Zn) points to a pos-
sible important contribution of DMT proteins to the uptake of Cd into the cells. As DMT-1 
is expressed in the kidney  [20] , it was investigated by quantitative real-time RT-PCR analysis 
whether exposure of the tubular cells to CdCl  2  goes along with an upregulation of the DMT-
1 gene expression.
  Fig. 1.  Intracellular accumulation of Cd in human kidney tubular cell cultures is dependent on concentra-
tion (  a  ) and incubation time (  b ).   a   Cells were grown until confluence and incubated at 37    °    C in    -MEM 
medium with different CdCl  2   concentrations (0, 20, 100, 200, and 500 n  M  ) for 5 h. Cd accumulation in 
the tubular cells was saturable, with a maximal cellular uptake of 641   8   76 pmol Cd/mg protein.   b   Con-
fluent cells were incubated with 500 n  M   CdCl 2   ( I  ) or 500 n  M   Cd7MT-1 (  y  ) for periods of 3, 5, 24, 48, and 
72 h. Intracellular accumulation kinetics were clearly different for both. Values are means  8  SEM of trip-
licate determinations, performed on cells originating from 3 different nephrectomies. In each of these 3 
experiments, triplicate determinations (3 wells) were performed for each condition. 29
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    After 5 h of CdCl  2   treatment, mRNA expression level of the gene encoding DMT-1 was 
not different from that in cultured human renal cells at control conditions (absence of Cd; 
  fig. 3  , open column). However, long-term (24–72 h) exposure to 500 n  M   CdCl 2   resulted in a 
significant (p   !   0.05 vs. control) increase in the DMT-1/GAPDH ratio.
  C d C l  2  -Induced Effects on the Expression of Genes Relevant to Nephrotoxic Processes 
  In this part of the study, we investigated whether inorganic CdCl  2   had an effect on the 
gene expression of key proteins in pathways relevant to nephrotoxic processes: MT-1 and 
HO-1 as protectors against oxidative stress; and Bax and Bcl-2 as pro- and anti-apoptotic 
genes, respectively. In addition, we examined in which way pre-incubation of the cells with 
an anti-oxidative agent (ebselen) influenced the expression of these genes.
    Treatment of the cells with CdCl  2   at physiologically relevant concentrations (20, 100, 
200, 500, and 1,000 n  M  ) during 5 h resulted in a concentration-dependent increase of MT-1 
  Fig. 2.   Intracellular accumulation of Cd, added to the cell culture medium as CdCl  2  , is pH dependent (  a ) 
and inhibited by Zn (  b ).   a   Confluent cells were incubated in glucose-containing buffered solution of pH 
5.5 or 7.4; 20 n  M   CdCl 2   was added for indicated time periods. Mean values of Cd  2+   accumulation at pH 
5.5 and 7.4 were significantly different from each other for incubation times 15 and 20 h.   b  Confluent cells 
were incubated with 500 n  M   CdCl 2   either in the presence or in the absence of 5     M   ZnCl 2  . The intracel-
lular Cd  2+   accumulation was significantly inhibited by the presence of Zn. Each data point represents 
means   8   SEM of 3 wells derived from tissue of the same nephrectomy.   *  p   !   0.05. 30
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mRNA levels, ranging from a 3-fold increase at 100 n  M   CdCl 2   up to a 140-fold increase at 
a concentration of 1,000 n M  CdCl 2  ( fig. 4 a, open columns). When the cells were treated with 
10     M   ebselen for 1 h, prior to CdCl  2   administration, a significantly (p   !   0.05) lower Cd  2+ -
induced production of MT-1 mRNA was observed. Although production of MT-1 was not 
completely abolished in any condition, at the highest CdCl  2   concentration (1,000 n  M ), 
mRNA levels of MT-1 were up to 3 times lower in ebselen-treated cells as compared to the 
non-treated cultures (  fig. 4  a, closed columns). With regard to the temporal effect of CdCl  2  
exposure on the MT-1 gene expression, a peak level was observed after 5 h of exposure of 
the cells to culture medium containing 500 n  M   CdCl 2  . With longer incubation periods, 
MT-1 mRNA expression again decreased reaching baseline levels after 48 h of treatment 
( fig. 4 b).
    Similar to MT-1, induction of HO-1 is an important cellular response and a well-recog-
nized biomarker for oxidative stress. Treatment of the cells with CdCl  2   for 5 h significantly 
and dose-dependently (CdCl  2   1 200 n M ) upregulated (4-fold) the expression of HO-1 mRNA 
in human tubular cells as compared to controls ( fig. 5 a). This upregulation of HO-1 was com-
pletely prevented by pre-incubation of the cells with 10     M   ebselen for 1 h. With regard to 
the temporal effect, relative expression of HO-1 mRNA after exposure to CdCl  2   for more 
than 5 h was not significantly different anymore from cells not incubated with CdCl  2  ( fig. 5 b).
  In comparison to controls, the Bax mRNA level was significantly higher when cells were 
exposed to 500 n  M   CdCl 2   for longer time periods (24–72 h). In contrast, the expression of 
Bcl-2 mRNA significantly decreased during this period. As a result, the Bax/Bcl-2 mRNA 
ratio significantly shifted in favor of Bax, yielding values of 1.4, 2.3, and 4.5 versus controls 
(set at 1.0) after 24, 48, and 78 h, respectively (  fig. 6  ). No significant effect was observed after 
a short (  !  24 h) exposure to CdCl  2 .
  Fig. 3.   Expression of DMT-1 (DMT-1/GAPDH) mRNA in human tubular cells affected by CdCl  2   expo-
sure. Confluent primary cultured cells were treated with 500 n  M  CdCl 2  during 0 (control), 3, 5, 24, 48, and 
72 h. DMT-1 and GAPDH mRNA levels were quantified by quantitative real-time RT-PCR; values ob-
tained from untreated (control) cells were set to 1. Relative DMT-1 expression (DMT-1/GAPDH) is sig-
nificantly upregulated starting at 24 h CdCl  2   incubation. Data represent means   8   SEM of triplicate ex-
periments on cells originating from the same nephrectomy.   *  p   !   0.05 as compared to control. 31
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    Cd7MT-1-Induced Effects on the Expression of Genes Relevant to Nephrotoxic Processes 
 MT-1 mRNA expression of cells incubated with 500 n  M  Cd7MT-1 remained below base-
line levels (data not shown). Moreover, in contrast to CdCl  2  , the presence of Cd7MT-1 re-
sulted in a reduction in HO-1 mRNA levels at 24, 48, and 72 h (  fig. 7  a). Additionally, where-
as CdCl  2  treatment significantly shifted the Bax/Bcl-2 mRNA ratio in favor of Bax, Cd7MT-1 
treatment significantly shifted the Bax/Bcl-2 mRNA ratio in favor of the anti-apoptotic Bcl-
2, yielding values of 1.4, 2.3, and 4.5 versus controls (set at 1.0) after 24, 48, and 78 h, respec-
tively  ( fig. 7 b).
  Fig. 4.   Expression of MT-1 mRNA in human tubular cells.   a   Relative expression of MT-1 (MT-1/GAPDH) 
mRNA in tubular cells treated for 5 h with different CdCl  2   concentrations (20–1,000 n  M  ), either or not 
pre-incubated with 10     M   ebselen. MT-1 mRNA was upregulated by CdCl  2  . Upregulation was signifi-
cantly prevented by ebselen pre-treatment.   b   Time course (3–72 h) of relative MT -1 (MT -1/GAPDH) 
mRNA expression in tubular cells after exposure to CdCl  2   (500 n  M  ). MT-1 mRNA expression was sig-
nificantly upregulated versus control during the short incubation times only. Columns represent means 
  8  SEM of triplicate experiments on cells originating from the same nephrectomy as in figure 3.  *  p  !  0.05. 32
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  Discussion 
  In the present study, the renal tubular handling of Cd  2+   was investigated by exposing 
primary human tubular cell cultures to physiologically relevant concentrations (20–1,000 
n  M  ) of Cd  2+   (administered as CdCl  2 ).  Cd 2+   accumulated into those cells in a concentration- 
and time-dependent manner. Furthermore, (time-dependent) cellular accumulation of Cd  2+  
was different from the cellular accumulation of Cd bound to metallothionein. Indeed, in 
contrast to the quick plateauing of Cd administered as CdCl  2  , Cd accumulation when ad-
ministered as Cd7MT-1 steadily increased over time during 72 h of treatment, suggesting 
different routes of uptake for both compounds.
  Fig. 5.  Expression of HO-1 mRNA in human tubular cells.   a  Relative expression of HO-1 (HO-1/GAPDH) 
mRNA in tubular cells treated for 5 h with different CdCl  2  concentrations (2–1,000 n  M ), either or not pre-
incubated with 10     M   ebselen. HO-1 mRNA was upregulated by CdCl  2  . Upregulation was significantly 
prevented by ebselen pre-treatment.   b   Time course (3–72 h) of relative HO-1 (HO-1/GAPDH) mRNA ex-
pression in tubular cells after exposure to CdCl  2   (500 n  M  ). HO-1 mRNA expression was significantly up-
regulated versus control after 5 h of incubation, while baseline expression was seen for the longer incuba-
tion periods. Columns represent means   8   SEM of triplicate experiments on cells originating from the 
same nephrectomy as in figures 3 and 4.   *  p   !   0.05. 33
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  Consensus exists in the literature regarding the uptake of Cd7MT-1 by the renal cell, and 
one may assume that Cd7MT-1 is internalized at the apical membrane of renal cells, espe-
cially proximal tubular cells, via RME   [21]  . RME of proteins has previously been studied in 
the primary human tubular cell culture model proposed here   [19]  . We found that this pro-
cess, in line with the in vivo     situation, occurs in cells originating from the proximal part of 
the tubule, while it was absent in cells originating from the more distal parts of the nephron. 
This result together with the notion that uptake of Cd7MT-1 is not saturable at the concen-
tration under study allows us to presume that the uptake of Cd7MT-1 in our cell cultures 
also took place through RME by the proximal tubular cells.
    In contrast to Cd7MT-1, the uptake pathway of Cd  2+   is much less known. Cd is a non-
essential metal and therefore most likely uses cellular entry pathways of other (essential) 
metals such as iron (Fe) and Zn. The finding that in our cell culture model, Cd accumulation 
in the cells was significantly higher at pH 5.5 as compared to pH 7.4, points to the involve-
ment of DMT-1 in the cellular uptake of Cd   [22, 23]  . This is further supported by our data 
showing that long-term exposure to CdCl  2   (  fig. 3  ) goes along with a significant and time-
dependent increase of the DMT-1 mRNA expression. An in-detail study of DMT-1 expres-
sion in the kidney indicated that, next to its lysosomal presence in the proximal tubule, DMT-
1 is also present at the apical membrane of cells in the thick ascending limb and more distal 
parts of the nephron   [20]  . Preliminary investigations of our group on Cd  2+   uptake in pure 
cultures of distal tubular cells revealed that Cd  2+   indeed is taken up by distal tubular cells as 
well. This is in line with a study of Olivi et al.   [24]   reporting DMT-1-mediated uptake of Cd 
(administered as CdCl  2 ) into MDCK cells, a cell line originating from the distal tubular part 
of the nephron.
    Although DMT-1 primarily is an Fe-transporting molecule, a recent study identified 
DMT-1 as a Zn-transporting molecule as well  [25] . Therefore, the dramatic inhibition of cel-
  Fig. 6.   Bax/Bcl-2 ratio in human tubular cells chronically treated with CdCl  2  . Confluent tubular cell cul-
tures were exposed to 500 n  M   CdCl 2   for different time periods (3–72 h). CdCl  2   treatment during 24 h or 
longer significantly increased the Bax/Bcl-2 ratio versus untreated control. Ratios of Bax/Bcl-2 mRNA 
levels were calculated from relative expression ratios (to GAPDH) of both genes. The results are means  8  
SEM of triplicate experiments on cells originating from the same nephrectomy.   *  p   !   0.05. 34
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lular Cd accumulation in the presence of Zn may also be indicative for a role of DMT-1 in 
cellular Cd transport. However, it also points to the potential contribution of other (Zn) 
transporters such as those of the ZIP family   [26]  . The further unraveling of the pathways 
involved in cellular Cd accumulation in different parts of the nephron would be an interest-
ing challenge for future investigations.
  In conclusion, the results described above make clear that the handling of the same con-
centrations of Cd in either its inorganic (CdCl  2  ) or organic form (Cd7MT-1) by human tu-
bular kidney cells is very different. These different kinetics point to different uptake path-
ways, which end up in different intracellular concentrations and most probably in a different 
intracellular localization as well. This incited us to check whether differences in cellular han-
dling of Cd also result in different effects on the expression of genes of which the protein 
products are known to play a role in cellular toxicity.
  Fig. 7.   The relative expression of the genes associated with the effects of Cd7MT-1.   a   Time course (3–72 h) 
of relative HO-1 (HO-1/GAPDH) mRNA expression in tubular cells after exposure to Cd7MT-1 (500 n  M ). 
HO-1 mRNA expression was significantly downregulated versus control for 24, 48, and 72 h incubation 
periods.   b   Cd7MT-1 treatment during 24 h or longer significantly increased the Bcl-2/Bax ratio versus 
untreated control. Ratios of Bcl-2/Bax mRNA levels were calculated from relative expression ratios (to 
GAPDH) of both genes. The results are means   8   SEM of triplicate experiments on cells originating from 
one nephrectomy (same as in figure 6).   *  p   !   0.05. 35
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    Unlike Fe and copper (Cu), Cd is not a Fenton metal and thus does not generate free 
radicals by itself. Hence, nowadays there is increasing evidence that ROS are generated in the 
presence of Cd   [27]   and that several proteins such as metallothioneins and heme-oxygenas-
es may act as early protective tools against oxidative stress. Our results are in line with this 
as they show that acute exposure (5 h) to high doses of CdCl  2   stimulates production of MT-1 
mRNA up to 140-fold as compared to controls (no exposure to CdCl  2  ). These results are in 
agreement with literature data showing increased transcription of MT-1 genes in response 
to acute exposure to particular metals. Moreover, in previous studies, it has been found that 
overexpression of MT-1 mRNA levels correlates well with increased production of the MT-1 
protein, suggesting that transcription rather than translation determines the Cd  2+ -induced 
upregulation of MT-1   [28]  .
  Together with MT-1, the induction of HO-1 has been established as a defense mechanism 
against oxidative stress. HO-1 expression increases following exposure to a wide variety of 
cellular stressors. HO-1 mRNA expression showed a similar temporal pattern as that seen 
for MT-1 mRNA, as the mRNA levels of HO-1 rapidly increased after an acute 5-hour expo-
sure to CdCl  2  , after which they again decreased to baseline values after longer exposure pe-
riods (24–72 h).
  In contrast to CdCl  2 , culturing of our cells in Cd7MT-1-containing cell culture medium 
did not result in upregulation of HO-1 or MT-1 mRNA expression. As a next step, the expres-
sion of MT-1 and HO-1 mRNA in response to Cd  2+   exposure was measured after pre-incu-
bating the cells with ebselen. Ebselen [2-phenyl-1,2-benzisoselenazol-3(2H)-one] is a seleni-
um-containing compound which has been shown to exhibit anti-oxidant, anti-nociceptive, 
neuroprotective and anti-inflammatory properties in various experimental models   [29–31]  . 
Thus, the rationale for pre-treating cells with ebselen was that if cellular upregulation of 
MT-1 and HO-1 mRNA protects cells against Cd  2+  -induced oxidative stress, a reduced up-
regulation of both genes must reasonably be expected in the presence of ebselen. Results in-
dicated that pre-incubation with ebselen indeed prevented the upregulation of HO-1 and 
MT-1 mRNA during Cd  2+   exposure.
  During the last decade, studies at the cellular level indicated that Cd may induce various 
biochemical changes associated with apoptosis   [32]  . Different families of proteins have been 
identified to play an important role in the apoptotic process. Of these, Bcl-2, an intracellular 
membrane-associated protein family, functions to inhibit apoptosis, whereas the Bax and 
BH3 families promote apoptosis   [33, 34]  . Hence, a shift in the Bax/Bcl-2 balance may modu-
late the cellular function either to pro- or to anti-apoptotic processes.
    The present study demonstrates that the Bax/Bcl-2 gene expression ratio is shifted to-
wards the apoptotic pathway when cells are treated with CdCl  2   ( fig. 6 ).  Interestingly,  the 
temporal increase in the Bax/Bcl-2 gene expression ratio at 24–72 h of incubation went along 
with the normalization (end of upregulation) of both the MT-1 and HO-1 mRNA expression. 
In this context, the observation that, in the presence of Cd7MT-1, the cellular response in 
contrast to CdCl  2   is in favor of Bcl-2 mRNA expression is interesting and in agreement with 
previous studies obtained on renal cells of porcine origin, in which overexpression of Bcl-2 
mRNA completely inhibited Cd-induced apoptosis   [35]  .
    In summary, in the presence of physiologically relevant Cd concentrations, tubular ac-
cumulation of the element in its inorganic form is different from that of Cd7MT-1. Further-
more, the tubular accumulation of inorganic Cd induces genes of which the protein products 
may play a role in Cd-associated renal toxicity, while this is not the case for Cd7MT-1. Indeed, 
whereas exposure to CdCl  2  induces an increase in MT-1 and HO-1 mRNA, expression of the 
genes remained below baseline levels in the presence of Cd7MT-1. Moreover, in contrast to 
Cd7MT-1, cellular exposure to CdCl  2   does result in an upregulation of pro-apoptotic genes. 
Finally, this study demonstrates that, in combination with a set of appropriate analytical 36
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techniques, our human primary cell culture system offers an excellent model to study the 
characteristics and toxicological consequences of cellular uptake of heavy metals at the level 
of the kidney.
  Acknowledgments 
  This work would not have been possible without the generous cooperation of Dr. Braek-
man (University Hospital, Brussels), Dr. Verkoelen and Dr. Asselman (Erasmus Medical 
Center, Rotterdam), Dr. Dekuyper (AZ Maria Middelares, Ghent) and Prof. Oosterlinck 
(University Hospital, Ghent).
  This work was funded by a BOF (‘Bijzonder Onderzoeksfonds’ – University of Antwerp) 
Bilateral Scientific Cooperation Programme between Flanders and Romania. Dr. Anja Ver-
hulst is a postdoctoral fellow of the Fund for Scientific Research Flanders (FWO).
    Dr. Dana Cucu acknowledges the POSDRU/89/1.5/S/60746 program.
  Disclosure  Statement 
  The authors confirm that there are no conflicts of interest.
 
 References 
   1  Thevenod F: Nephrotoxicity and the proximal tubule. Insights from cadmium. Nephron Physiol 
2003;    93:   87–93. 
   2  Zalups RK, Ahmad S: Molecular handling of cadmium in transporting epithelia. Toxicol Appl Phar-
macol 2003;    186:   163–188. 
    3  Elinder CG, Lind B, Kjellstrom T, Linnman L, Friberg L: Cadmium in kidney cortex, liver, and pan-
creas from Swedish autopsies. Estimation of biological half time in kidney cortex, considering calorie 
intake and smoking habits. Arch Environ Health 1976;    31:   292–302. 
    4  Lewis GP, Coughlin LL, Jusko WJ, Hartz S: Contribution of cigarette smoking to cadmium accumu-
lation in man. Lancet 1972;    1:   291–292. 
   5  Diamond GL, Goodrum PE, Felter SP, Ruoff WL: Gastrointestinal absorption of metals. Drug Chem 
Toxicol 1998;    21:   223–251. 
    6  Habeebu SS, Liu J, Klaassen CD: Cadmium-induced apoptosis in mouse liver. Toxicol Appl Pharma-
col 1998;    149:   203–209. 
   7  Nordberg GF: Cadmium and health in the 21st century – historical remarks and trends for the future. 
Biometals 2004;    17:   485–489. 
   8  Svartengren M, Elinder CG, Friberg L, Lind B: Distribution and concentration of cadmium in human 
kidney. Environ Res 1986;    39:   1–7. 
   9  Nordberg GF: Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol 2009;    238:  
 192–200. 
  10  Lauwerys R, Roels H, Regniers M, Buchet JP, Bernard A, Goret A: Significance of cadmium concen-
tration in blood and in urine in workers exposed to cadmium. Environ Res 1979;    20:   375–391. 
 11  Minoia C, Sabbioni E, Apostoli P, Pietra R, Pozzoli L, Gallorini M, Nicolaou G, Alessio L, Capodaglio 
E: Trace element reference values in tissues from inhabitants of the European community. I. A study 
of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ 1990;    95:   89–105. 
  12  Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M: Health effects of cadmium exposure – a 
review of the literature and a risk estimate. Scand J Work Environ Health 1998;    24(suppl  1):1–51. 
 13  Suwazono Y, Sand S, Vahter M, Filipsson AF, Skerfving S, Lidfeldt J, Akesson A: Benchmark dose for 
cadmium-induced renal effects in humans. Environ Health Perspect 2006;    114:   1072–1076. 37
Nephron Extra 2011;1:24–37
 DOI:  10.1159/000330069 
EXTRA
  Cucu et al.: Low-Dose Cadmium Exposure to Human Tubular Cells 
www.karger.com/nne
  © 2011 S. Karger AG, Basel 
  Published online: August 12, 2011 
 14  Barbier O, Jacquillet G, Tauc M, Poujeol P, Cougnon M: Acute study of interaction among cadmium, 
calcium, and zinc transport along the rat nephron in vivo. Am J Physiol Renal Physiol 2004;    287:F1067–
F1075. 
  15  Gennari A, Cortese E, Boveri M, Casado J, Prieto P: Sensitive endpoints for evaluating cadmium-
induced acute toxicity in LLC-PK1 cells. Toxicology 2003;    183:   211–220. 
 16  Lijnen P, Staessen J, Fagard R, Amery A: Effect of cadmium on transmembrane Na  +  and K  +  transport 
systems in human erythrocytes. Br J Ind Med 1991;    48:   392–398. 
  17  Kazantzis G: Cadmium, osteoporosis and calcium metabolism. Biometals 2004;    17:   493–498. 
  18  Savolainen H: Cadmium-associated renal disease. Ren Fail 1995;    17:   483–487. 
 19  Verhulst A, D’Haese PC, De Broe ME: Inhibitors of HMG-COA reductase reduce receptor-mediated 
endocytosis in human kidney proximal tubular cells. J Am Soc Nephrol 2004;    15:   2249–2257. 
  20  Ferguson CJ, Wareing M, Ward DT, Green R, Smith CP, Riccardi D: Cellular localization of divalent 
metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol 2001;    280:F803–F814. 
  21  Abouhamed M, Wolff NA, Lee WK, Smith CP, Thevenod F: Knockdown of endosomal/lysosomal 
divalent metal transporter 1 by RNA interference prevents cadmium-metallothionein-1 cytotoxicity 
in renal proximal tubule cells. Am J Physiol Renal Physiol 2007;    293:F705–F712. 
  22  Bannon DI, Abounader R, Lees PS, Bressler JP: Effect of DMT1 knockdown on iron, cadmium, and 
lead uptake in Caco-2 cells. Am J Physiol Cell Physiol 2003;    284:C44–C50. 
  23  Lam-Yuk-Tseung S, Govoni G, Forbes J, Gros P: Iron transport by Nramp2/DMT1: pH regulation of 
transport by 2 histidines in transmembrane domain 6. Blood 2003;    101:   3699–3707. 
 24  Olivi L, Sisk J, Bressler J: Involvement of DMT1 in uptake of Cd in MDCK cells: role of protein kinase 
C. Am J Physiol Cell Physiol 2001;    281:C793–C800. 
  25  Deng Z, Dailey LA, Soukup J, Stonehuerner J, Richards JD, Callaghan KD, Yang F, Ghio AJ: Zinc 
transport by respiratory epithelial cells and interaction with iron homeostasis. Biometals 2009;    22:  
 803–815. 
 26  Lichten LA, Cousins RJ: Mammalian zinc transporters: nutritional and physiologic regulation. Annu 
Rev Nutr 2009;    29:   153–176. 
  27  Thevenod F, Friedmann JM: Cadmium-mediated oxidative stress in kidney proximal tubule cells 
induces degradation of Na+/K(+)-ATPase through proteasomal and endo-/lysosomal proteolytic 
pathways. FASEB J 1999;    13:   1751–1761. 
 28  Zalups RK, Koropatnick J: Temporal changes in metallothionein gene transcription in rat kidney and 
liver: relationship to content of mercury and metallothionein protein. J Pharmacol Exp Ther 2000;   
 295:   74–82. 
 29  Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS: Ne-
phropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by 
chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004;    15:   2391–2403. 
  30  Meotti FC, Borges VC, Zeni G, Rocha JB, Nogueira CW: Potential renal and hepatic toxicity of di-
phenyl diselenide, diphenyl ditelluride and ebselen for rats and mice. Toxicol Lett 2003;    143:   9–16. 
  31  Nogueira CW, Quinhones EB, Jung EA, Zeni G, Rocha JB: Anti-inflammatory and antinociceptive 
activity of diphenyl diselenide. Inflamm Res 2003;    52:   56–63. 
  32  Robertson JD, Orrenius S: Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit 
Rev Toxicol 2000;    30:   609–627. 
  33  Adams JM, Cory S: Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Im-
munol 2007;    19:   488–496. 
  34  Fernandez-Luna JL: Apoptosis regulators as targets for cancer therapy. Clin Transl Oncol 2007;    9:  
 555–562. 
  35  Ishido M, Ohtsubo R, Adachi T, Kunimoto M: Attenuation of both apoptotic and necrotic actions of 
cadmium by BCL-2. Environ Health Perspect 2002;    110:   37–42. 
  